fremanezumab

Migraine has been linked to depression and anxiety and they often co-exist. Together they increase the frequency and severity of headaches. According to a study presented at the recently concluded 2021 online Psych Congress, treatment with the antimigraine drug fremanezumab may help to wean off antidepressant medications in patients with migraine and concurrent depression and anxiety.The study included 172 patients with migraine (chronic or episodic) and who had comorbid depression, 180 patients…

Leave a comment